ARTICLE SUMMARY:
Orthopedics companies have redefined their customer base and re-set their business propositions in response to the growth of CMS-initiated bundled payment programs. After HHS announced in August that it is easing some bundle requirements, experts weigh in on the evidence of the impact to date of such programs on value-based medicine, and what’s in it for companies.
The Center for Medicare and Medicaid Services’ (CMS) proposals, announced August 15, to roll back some of the federal government’s most sweeping and controversial bundled payment initiatives is drawing cautiously positive responses from experts in the orthopedics world.
